← Back

Wire · regulatory

US Gov't Makes Next Move to Onshore Mfg of Generics

Published

2 October 2026

Topic

regulatory

◆ Sectors

Pharma & Biotech

◆ Geography

United States

◆ Source

Read at dcatvci.org →

◆ Verified

Fusion42 · 3 October 2026 · Fusion42 review

The US government, through the Office of Management and Budget, is seeking information from manufacturers on existing and potential domestic or near-shore production capacity for 86 essential generic medicines to reduce dependence on foreign suppliers and secure the supply chain.

This Wire brief sits within Fusion42's coverage of Pharma & Biotech.

◆ ◆ The Wire takeaway

Manufacturers with idle or planned US or near-shore capacity for essential generic medicines now have a clear federal path to influence contract opportunities and partnerships. Your production site location and capability details could become the key to new government work and financial support.

◆ Coverage

1 source · 2 Oct 2026

◆ Related on Wire

◆ Topics

Pharma & Biotechgeneric-medicinesonshoringsupply-chainfederal-policypharmaceutical-manufacturing